Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07856082) titled 'Opt-IVF for Personalized Medicine for Normal Responders' on Sept. 28.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: Urmila DIwekar
Condition:
Ivf
Intervention:
Device: Opt-IVF
Recruitment Status: Recruiting
Phase: Phase 1/Phase 2
Date of First Enrollment: October 15, 2026
Target Sample Size: 100
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07856082
Published by HT Digital Content Services with permi...